Davis R M Inc
- SEC CIK
- 0000891287
- Latest filing
- Aug 14, 2026
PFE holding history
Pfizer Inc in every 13F filed by Davis R M Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 12,484
- Value
- $300.6K
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 12,484 | $300.6K | <0.1% | −813−6.1% | Reduced | Holders |
| Q1 2026 | 13,297 | $373.4K | <0.1% | +1,493+12.6% | Added | Holders |
| Q4 2025 | 11,804 | $293.9K | <0.1% | −1,083−8.4% | Reduced | Holders |
| Q3 2025 | 12,887 | $328.4K | <0.1% | −655−4.8% | Reduced | Holders |
| Q2 2025 | 13,542 | $328.3K | <0.1% | −9,747−41.9% | Reduced | Holders |
| Q1 2025 | 23,289 | $590.1K | <0.1% | −1,034−4.3% | Reduced | Holders |
| Q4 2024 | 24,323 | $645.3K | <0.1% | −28,734−54.2% | Reduced | Holders |
| Q3 2024 | 53,057 | $1.54M | <0.1% | −6,977−11.6% | Reduced | Holders |
| Q2 2024 | 60,034 | $1.68M | <0.1% | −12,497−17.2% | Reduced | Holders |
| Q1 2024 | 72,531 | $2.01M | <0.1% | −31,628−30.4% | Reduced | Holders |
| Q4 2023 | 104,159 | $3.00M | 0.1% | −174,944−62.7% | Reduced | Holders |
| Q3 2023 | 279,103 | $9.26M | 0.2% | −67,829−19.6% | Reduced | Holders |
| Q2 2023 | 346,932 | $12.7M | 0.3% | +9,375+2.8% | Added | Holders |
| Q1 2023 | 337,557 | $13.8M | 0.4% | +14,509+4.5% | Added | Holders |
| Q4 2022 | 323,048 | $16.6M | 0.4% | +18,822+6.2% | Added | Holders |
| Q3 2022 | 304,226 | $13.3M | 0.4% | −16,897−5.3% | Reduced | Holders |
| Q2 2022 | 321,123 | $16.8M | 0.5% | +317+0.1% | Added | Holders |
| Q1 2022 | 320,806 | $16.6M | 0.4% | +4,148+1.3% | Added | Holders |
| Q4 2021 | 316,658 | $18.7M | 0.4% | +9,290+3.0% | Added | Holders |
| Q3 2021 | 307,368 | $13.2M | 0.3% | +7,616+2.5% | Added | Holders |
| Q2 2021 | 299,752 | $11.7M | 0.3% | +25,002+9.1% | Added | Holders |
| Q1 2021 | 274,750 | $9.95M | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.